These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27746276)

  • 41. Hydrogels in pharmaceutical formulations.
    Peppas NA; Bures P; Leobandung W; Ichikawa H
    Eur J Pharm Biopharm; 2000 Jul; 50(1):27-46. PubMed ID: 10840191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved Skin Penetration Using In Situ Nanoparticulate Diclofenac Diethylamine in Hydrogel Systems: In Vitro and In Vivo Studies.
    Sengupta S; Banerjee S; Sinha B; Mukherjee B
    AAPS PharmSciTech; 2016 Apr; 17(2):307-17. PubMed ID: 26089167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation of in situ chemically cross-linked hydrogel depots for protein release: from the blob model perspective.
    Yu Y; Chau Y
    Biomacromolecules; 2015 Jan; 16(1):56-65. PubMed ID: 25314589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants.
    Hernandez C; Gawlik N; Goss M; Zhou H; Jeganathan S; Gilbert D; Exner AA
    J Control Release; 2016 Dec; 243():225-231. PubMed ID: 27742445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of pH- and temperature-sensitive hydrogel nanoparticles for controlled drug release.
    Chen H; Gu Y; Hub Y; Qian Z
    PDA J Pharm Sci Technol; 2007; 61(4):303-13. PubMed ID: 17933211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
    Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
    Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluxgate magnetorelaxometry: a new approach to study the release properties of hydrogel cylinders and microspheres.
    Wöhl-Bruhn S; Heim E; Schwoerer A; Bertz A; Harling S; Menzel H; Schilling M; Ludwig F; Bunjes H
    Int J Pharm; 2012 Oct; 436(1-2):677-84. PubMed ID: 22820133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
    Selvam P; El-Sherbiny IM; Smyth HD
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimuli-responsive hydrogels in drug delivery and tissue engineering.
    Sood N; Bhardwaj A; Mehta S; Mehta A
    Drug Deliv; 2016; 23(3):758-80. PubMed ID: 25045782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formation, characterization, and fate of inhaled drug nanoparticles.
    Zhang J; Wu L; Chan HK; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patents on nanoparticulate drug delivery systems--a review.
    Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(1):83-9. PubMed ID: 19075900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic applications of hydrogels in oral drug delivery.
    Sharpe LA; Daily AM; Horava SD; Peppas NA
    Expert Opin Drug Deliv; 2014 Jun; 11(6):901-15. PubMed ID: 24848309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.
    Rajitha P; Gopinath D; Biswas R; Sabitha M; Jayakumar R
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1177-94. PubMed ID: 27087148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (Macro)molecular self-assembly for hydrogel drug delivery.
    Webber MJ; Pashuck ET
    Adv Drug Deliv Rev; 2021 May; 172():275-295. PubMed ID: 33450330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic applications of electrospun nanofibers for drug delivery systems.
    Son YJ; Kim WJ; Yoo HS
    Arch Pharm Res; 2014 Jan; 37(1):69-78. PubMed ID: 24234913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic hydrogels as drug delivery systems.
    Roorda WE; Boddé HE; De Boer AG; Bouwstra JA; Junginer HE
    Pharm Weekbl Sci; 1986 Jun; 8(3):165-89. PubMed ID: 3526277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.
    Kimura M; Takai M; Ishihara K
    J Biomed Mater Res A; 2007 Jan; 80(1):45-54. PubMed ID: 16958047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applications of biomimetic systems in drug delivery.
    Venkatesh S; Byrne ME; Peppas NA; Hilt JZ
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1085-96. PubMed ID: 16296811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.